Development of a Counterselectable Seamless Mutagenesis System in Lactic Acid Bacteria
Overview
Microbiology
Authors
Affiliations
Background: Lactic acid bacteria (LAB) are receiving more attention to act as cell factories for the production of high-value metabolites. However, the molecular tools for genetic modifying these strains are mainly vector-based double-crossover strategies, which are laborious and inefficient. To address this problem, several counterselectable markers have been developed, while few of them could be used in the wild-type host cells without pretreatment.
Results: The pheS gene encoding phenylalanyl-tRNA synthetase alpha subunit was identified in Lactococcus lactis NZ9000 genome. When mutant pheS gene (pheS*) under the control of the Lc. lactis NZ9000 L-lactate dehydrogenase promoter (P) was expressed from a plasmid, the resulted PheS* with an A312G substitution rendered cells sensitive to the phenylalanine analog p-chloro-phenylalanine (p-Cl-Phe). This result suggested pheS* was suitable to be used as a counterselectable marker in Lc. lactis. However, the expression level of pheS* from a chromosomal copy was too low to confer p-Cl-Phe sensitivity. Therefore, a strategy of cascading promoters was attempted for strengthening the expression level of pheS*. Expectedly, a cassette 5Pldh-pheS* with five tandem repetitive promoters P resulted in a sensitivity to 15 mM p-Cl-Phe. Subsequently, a counterselectable seamless mutagenesis system PheS*/pGhost9 based on a temperature-sensitive plasmid pGhost9 harboring a 5Pldh-pheS* cassette was developed in Lc. lactis. We also demonstrated the possibility of applying pheS* to be a counterselectable marker in Lactobacillus casei BL23.
Conclusions: As reported in E. coli, pheS* as a counterselectable marker has been demonstrated to be functional in targeted gene(s) deletion in Lc. lactis as well as in L. casei. Moreover, the efficiency and timesaving counterselectable seamless mutagenesis system PheS*/pGhost9 could be used in the wild-type host cells without pretreatment.
Pioneering precision in markerless strain development for Synechococcus sp. PCC 7002.
Tsuji A, Inabe K, Hidese R, Kato Y, Domingues L, Kondo A Microb Cell Fact. 2024; 23(1):268.
PMID: 39379966 PMC: 11462663. DOI: 10.1186/s12934-024-02543-6.
Advancements in gene editing technologies for probiotic-enabled disease therapy.
Wang L, Hu J, Li K, Zhao Y, Zhu M iScience. 2024; 27(9):110791.
PMID: 39286511 PMC: 11403445. DOI: 10.1016/j.isci.2024.110791.
Zheng Y, Deng Y, Hu P, Wang S, Wu J, Luo S Microb Cell Fact. 2024; 23(1):212.
PMID: 39061053 PMC: 11282862. DOI: 10.1186/s12934-024-02488-w.
Efficient markerless genetic manipulation of using and m as selection markers.
Jiang J, Zhao Y, Chen A, Sun J, Zhou M, Hu J Appl Environ Microbiol. 2024; 90(4):e0204323.
PMID: 38547470 PMC: 11022533. DOI: 10.1128/aem.02043-23.
Zheng Y, Fu H, Chen J, Li J, Bian Y, Hu P Microb Cell Fact. 2023; 22(1):208.
PMID: 37833755 PMC: 10571335. DOI: 10.1186/s12934-023-02217-9.